Yes, the deal has been done, probably around the 5.2c mark, to allow for the rerated share price as a result of the dilution, and a carrot to invest at all.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025